Furthermore, probiotics mitigated MCLR-induced lipid metabolism disorders by modulating key lipid metabolites (triglycerides, cholesterol, bile acids, and free fatty acids) and regulating the expression of lipid metabolism-related genes (ppara, pparb, srebp1, and nr1h4). The gene discussed is SREBF1; the disease is Disorder of lipid metabolism.